Are direct-acting antivirals against hepatitis C virus infection not associated with the recurrence of hepatocellular carcinoma?

Схожие документы

• Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
  по: Kanda, Tatsuo, et al.
  Опубликовано: (2017)
• Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus
  по: Kanda, Tatsuo, et al.
  Опубликовано: (2015)
• Relation of Reduction of Antibodies against Hepatitis B Virus to Hepatocellular Carcinoma Recurrence in the Patients with Resolved Hepatitis B Virus Infection Following Direct-acting Antiviral Therapy for Hepatitis C Virus Infection
  по: Joko, Kouji, et al.
  Опубликовано: (2019)
• Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b
  по: Kanda, Tatsuo, et al.
  Опубликовано: (2017)
• Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
  по: Sasaki, Reina, et al.
  Опубликовано: (2018)